Kenvue (KVUE) Stock: Charts & Financials

Kenvue Inc. (KVUE)KVUEKenvue Inc.

About Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Summit, NJ

22,000 employees

www.kenvue.com

Consumer Defensive / Household & Personal Products

Sector: Consumer Defensive
Industry: Household & Personal Products
CEO: Kirk L. Perry

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Total Current Assets	5.90B	5.90B	5.79B	5.70B	6.03B	5.85B	5.71B	5.53B	5.94B
Cash & Cash Equivalents	1.11B	1.11B	1.07B	1.06B	1.14B	1.07B	1.06B	1.07B	1.06B
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	1.11B	1.11B	1.07B	1.06B	1.14B	1.07B	1.06B	1.07B	1.06B
Accounts Receivable	0.00	0.00	2.91B	2.81B	2.95B	2.86B	2.82B	2.66B	2.85B
Inventory	1.72B	1.72B	1.67B	1.67B	1.79B	1.78B	1.68B	1.59B	1.82B
Total Assets	26.73B	26.73B	26.85B	27.08B	27.25B	27.13B	26.26B	25.60B	26.93B
Property, Plant & Equipment	2.23B	2.23B	2.21B	2.21B	2.09B	2.04B	1.93B	1.85B	1.78B
Goodwill	9.27B	9.27B	9.38B	9.51B	9.44B	9.49B	9.14B	8.84B	9.30B
Intangible Assets	8.41B	8.41B	8.54B	8.69B	8.72B	8.80B	8.59B	8.47B	8.89B
Long-Term Investments	0.00	0.00	0.00	0.00	1.00M	0.00	0.00	0.00	0.00
Total Current Liabilities	5.87B	5.87B	5.90B	5.95B	6.16B	5.99B	6.67B	5.74B	5.95B
Accounts Payable	2.58B	2.58B	2.53B	2.47B	2.44B	2.57B	2.33B	2.25B	2.27B
Short-Term Debt	1.41B	1.41B	1.59B	1.45B	1.91B	1.55B	2.43B	1.55B	1.65B
Total Liabilities	16.18B	16.18B	16.25B	16.31B	16.61B	16.40B	16.20B	15.93B	16.28B
Long-Term Debt	7.07B	7.07B	7.07B	7.07B	7.06B	7.06B	6.20B	6.94B	7.05B
Total Debt	8.48B	8.48B	8.66B	8.52B	9.11B	8.74B	8.85B	8.72B	8.83B
Net Debt (Cash)	7.37B	7.37B	7.59B	7.46B	7.97B	7.67B	7.80B	7.65B	7.77B
Total Shareholders' Equity	10.55B	10.55B	10.61B	10.77B	10.63B	10.73B	10.05B	9.67B	10.64B
Common Stock	19.00M	19.00M	19.00M	19.00M	19.00M	19.00M	19.00M	19.00M	19.00M
Retained Earnings	-70.00M	-70.00M	-128.00M	-204.00M	-136.00M	-136.00M	-163.00M	-93.00M	7.00M
Current Ratio	1.01	1.01	0.98	0.96	0.98	0.98	0.86	0.96	1.00
Debt to Equity Ratio	0.80	0.80	0.82	0.79	0.86	0.81	0.88	0.90	0.83

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Total Current Assets

5.90B

5.79B

5.70B

6.03B

5.85B

5.71B

5.53B

5.94B

Cash & Cash Equivalents

1.11B

1.07B

1.06B

1.14B

1.07B

1.06B

1.07B

1.06B

Short-Term Investments

0.00

Cash & Short-Term Investments

1.11B

1.07B

1.06B

1.14B

1.07B

1.06B

1.07B

1.06B

Accounts Receivable

0.00

2.91B

2.81B

2.95B

2.86B

2.82B

2.66B

2.85B

Inventory

1.72B

1.67B

1.79B

1.78B

1.68B

1.59B

1.82B

Total Assets

26.73B

26.85B

27.08B

27.25B

27.13B

26.26B

25.60B

26.93B

Property, Plant & Equipment

2.23B

2.21B

2.09B

2.04B

1.93B

1.85B

1.78B

Goodwill

9.27B

9.38B

9.51B

9.44B

9.49B

9.14B

8.84B

9.30B

Intangible Assets

8.41B

8.54B

8.69B

8.72B

8.80B

8.59B

8.47B

8.89B

Long-Term Investments

0.00

1.00M

0.00

Total Current Liabilities

5.87B

5.90B

5.95B

6.16B

5.99B

6.67B

5.74B

5.95B

Accounts Payable

2.58B

2.53B

2.47B

2.44B

2.57B

2.33B

2.25B

2.27B

Short-Term Debt

1.41B

1.59B

1.45B

1.91B

1.55B

2.43B

1.55B

1.65B

Total Liabilities

16.18B

16.25B

16.31B

16.61B

16.40B

16.20B

15.93B

16.28B

Long-Term Debt

7.07B

7.06B

6.20B

6.94B

7.05B

Total Debt

8.48B

8.66B

8.52B

9.11B

8.74B

8.85B

8.72B

8.83B

Net Debt (Cash)

7.37B

7.59B

7.46B

7.97B

7.67B

7.80B

7.65B

7.77B

Total Shareholders' Equity

10.55B

10.61B

10.77B

10.63B

10.73B

10.05B

9.67B

10.64B

Common Stock

19.00M

Retained Earnings

-70.00M

-128.00M

-204.00M

-136.00M

-163.00M

-93.00M

7.00M

Current Ratio

1.01

0.98

0.96

0.98

0.86

0.96

1.00

Debt to Equity Ratio

0.80

0.82

0.79

0.86

0.81

0.88

0.90

0.83

Annual Report	12/28/2025	12/29/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Total Current Assets	5.70B	5.53B	6.14B	5.88B	4.93B	4.59B	N/A
Cash & Cash Equivalents	1.06B	1.07B	1.38B	1.23B	740.00M	618.00M	N/A
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	N/A
Cash & Short-Term Investments	1.06B	1.07B	1.38B	1.23B	740.00M	618.00M	N/A
Accounts Receivable	2.81B	2.66B	2.64B	2.30B	2.33B	2.13B	N/A
Inventory	1.67B	1.59B	1.85B	2.23B	1.70B	1.69B	180.00M
Total Assets	27.08B	25.60B	27.85B	27.32B	27.93B	29.18B	N/A
Property, Plant & Equipment	2.21B	1.85B	2.04B	1.82B	1.83B	1.96B	N/A
Goodwill	9.51B	8.84B	9.27B	9.19B	9.81B	10.33B	N/A
Intangible Assets	8.69B	8.47B	9.62B	9.85B	10.70B	11.61B	N/A
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	N/A
Total Current Liabilities	5.95B	5.74B	5.48B	3.93B	4.04B	7.49B	N/A
Accounts Payable	2.47B	2.25B	2.49B	1.83B	1.83B	1.58B	N/A
Short-Term Debt	1.45B	1.55B	599.00M	0.00	0.00	0.00	N/A
Total Liabilities	16.31B	15.93B	16.64B	7.35B	7.53B	10.82B	N/A
Long-Term Debt	7.07B	6.94B	7.69B	8.93B	0.00	0.00	N/A
Total Debt	8.52B	8.72B	8.43B	9.05B	129.00M	0.00	N/A
Net Debt (Cash)	7.46B	7.65B	7.04B	7.82B	-611.00M	-618.00M	N/A
Total Shareholders' Equity	10.77B	9.67B	11.21B	19.97B	20.40B	18.36B	N/A
Common Stock	19.00M	19.00M	19.00M	0.00	0.00	0.00	N/A
Retained Earnings	-204.00M	-93.00M	429.00M	0.00	0.00	0.00	N/A
Current Ratio	0.96	0.96	1.12	1.50	1.22	0.61	N/A
Debt to Equity Ratio	0.79	0.90	0.75	0.45	0.01	0.00	N/A

Annual Report

12/28/2025

12/29/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

Total Current Assets

5.70B

5.53B

6.14B

5.88B

4.93B

4.59B

N/A

Cash & Cash Equivalents

1.06B

1.07B

1.38B

1.23B

740.00M

618.00M

N/A

Short-Term Investments

0.00

N/A

Cash & Short-Term Investments

1.06B

1.07B

1.38B

1.23B

740.00M

618.00M

N/A

Accounts Receivable

2.81B

2.66B

2.64B

2.30B

2.33B

2.13B

N/A

Inventory

1.67B

1.59B

1.85B

2.23B

1.70B

1.69B

180.00M

Total Assets

27.08B

25.60B

27.85B

27.32B

27.93B

29.18B

N/A

Property, Plant & Equipment

2.21B

1.85B

2.04B

1.82B

1.83B

1.96B

N/A

Goodwill

9.51B

8.84B

9.27B

9.19B

9.81B

10.33B

N/A

Intangible Assets

8.69B

8.47B

9.62B

9.85B

10.70B

11.61B

N/A

Long-Term Investments

0.00

N/A

Total Current Liabilities

5.95B

5.74B

5.48B

3.93B

4.04B

7.49B

N/A

Accounts Payable

2.47B

2.25B

2.49B

1.83B

1.58B

N/A

Short-Term Debt

1.45B

1.55B

599.00M

0.00

N/A

Total Liabilities

16.31B

15.93B

16.64B

7.35B

7.53B

10.82B

N/A

Long-Term Debt

7.07B

6.94B

7.69B

8.93B

0.00

N/A

Total Debt

8.52B

8.72B

8.43B

9.05B

129.00M

0.00

N/A

Net Debt (Cash)

7.46B

7.65B

7.04B

7.82B

-611.00M

-618.00M

N/A

Total Shareholders' Equity

10.77B

9.67B

11.21B

19.97B

20.40B

18.36B

N/A

Common Stock

19.00M

0.00

N/A

Retained Earnings

-204.00M

-93.00M

429.00M

0.00

N/A

Current Ratio

0.96

1.12

1.50

1.22

0.61

N/A

Debt to Equity Ratio

0.79

0.90

0.75

0.45

0.01

0.00

N/A

Balance Sheet

Quarterly Balance Sheet (USD)

Annual Balance Sheet (USD)